Based on these results, we studied the levels of GP88 and miR-486 in the serum of PCa patients, correlated them with clinicopathological parameters, and investigated whether these parameters could be indicative of the therapy intention of active surveillance or definitive curative treatment in PCa. Here, GRN is linked to posterior cortical atrophy.